CD44 and breast cancer: This data suggested that R-RAS2 is required to promote CD44-mediated migration of BC CBM-MBC21 cells through extracellular matrices rich in hyaluronic acid and therefore, that R-RAS2 mediates intracellular signaling by CD44 during BC cell migration.